Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of oxytocin in adults with binge-eating disorder; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Binge-eating Disorder | Phase 2 | Status: RECRUITING